Join us for ongoing discussions with our clinician-bloggers,
Paul Sax, MD
HIV and ID Observations
An ongoing dialogue on HIV/AIDS, infectious diseases,
all matters medical, and some not so medical
Recent Posts
On-Service ID Link-o-Rama — Osmosis Edition • April 30, 2025
First-year ID fellows this time of year bring a lot to inpatient consult rotations. Years of high-volume inpatient care have sharpened their clinical instincts, and at this point they have an impressive fund of ID knowledge. Plus, the fellow on our current rotation gets along great with everyone — patients and consulting clinicians alike — […]
2021-2022
Chief Resident Panel:
Abdullah Al‑abcha, MD
Mikita Arora, MD
Madiha Khan, DO
Mikita Arora, MD
Khalid A. Shalaby, MBBCh
Brandon Temte, DO
Insights on Residency Training
Notes from chief residents in family and internal medicine
Recent Posts
Developing Resident Educators • August 19, 2022 • Brandon Temte, DO
We currently find ourselves at the start of another academic year. By this time in August, many medical trainees are settling into new roles. Recently graduated medical students are getting used to hearing Dr. before their name. New senior residents who were interns a short time ago now find themselves leaders of their own teams. […]
Follow us on:
Apple Podcasts
YouTube
Spotify
Clinical Conversations
This podcast features lively interviews, concise summaries, and expert commentary that busy clinicians need to stay current and improve patient care.
Recent Posts
Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 • September 2, 2022
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK. In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-days of antibiotics. But what if a shorter course of antibiotic therapy would do? That would be both convenient for patients and less likely to promote […]
The post Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 first appeared on Clinical Conversations.Statements and opinions expressed in these blogs reflect the views of the author(s) and not necessarily the official policy of NEJM Journal Watch, NEJM Group, or the Massachusetts Medical Society, unless so stated.
NEJM Journal Watch — Recent Infectious Diseases Articles- Treating Gonorrhea — The Present and the Future
- Tecovirimat Against Clade I MPXV Infection — Does This Antiviral Make a Difference?
- Measles 2025: Update on the Situation in the U.S.
- More Than Companionship: Canine Serology Helps Define Coccidioidal Endemicity in the U.S.
- Vimkunya: The Second Chikungunya Vaccine to Be Licensed in the U.S.
- NEJM Journal Watch — Recent General Medicine Articles
- A Behavioral Activation App for Primary Care Patients with Depression
- Oral vs. Intramuscular Naltrexone for Patients Hospitalized with Alcohol Use Disorder
- Negative-Pressure Wound Therapy for Lower-Extremity Surgical Wounds
- New Steroid Dosing Strategy for Alcohol-Associated Hepatitis
- Are Results of Bronchodilator Testing Affected by Time of Day or Season?